Semi-Annual Consolidated Statement Of Comprehensive Income

Delta-Fly Pharma, Inc. - Filing #7296920

Concept 2024-04-01 to
2024-09-30
2023-04-01 to
2023-09-30
Semi-annual consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
-917,147,000 JPY
-600,287,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.